Fintel reports that on November 3, 2025, Baird maintained coverage of ResMed (NYSE:RMD) with a Outperform recommendation.
Analyst Price Forecast Suggests 20.94% Upside
As of October 30, 2025, the average one-year price target for ResMed is $301.14/share. The forecasts range from a low of $217.15 to a high of $346.50. The average price target represents an increase of 20.94% from its latest reported closing price of $249.00 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for ResMed is 4,804MM, a decrease of 8.62%. The projected annual non-GAAP EPS is 8.94.
What is the Fund Sentiment?
There are 1,715 funds or institutions reporting positions in ResMed. This is an increase of 93 owner(s) or 5.73% in the last quarter. Average portfolio weight of all funds dedicated to RMD is 0.23%, an increase of 5.40%. Total shares owned by institutions decreased in the last three months by 0.95% to 102,697K shares. 
The put/call ratio of RMD is 3.65, indicating a bearish outlook.
What are Other Shareholders Doing?
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 4,714K shares representing 3.23% ownership of the company. In its prior filing, the firm reported owning 4,644K shares , representing an increase of 1.49%. The firm increased its portfolio allocation in RMD by 4.38% over the last quarter.
Bank of New York Mellon holds 4,553K shares representing 3.12% ownership of the company. In its prior filing, the firm reported owning 5,046K shares , representing a decrease of 10.82%. The firm decreased its portfolio allocation in RMD by 92.34% over the last quarter.
Geode Capital Management holds 4,215K shares representing 2.89% ownership of the company. In its prior filing, the firm reported owning 4,116K shares , representing an increase of 2.34%. The firm increased its portfolio allocation in RMD by 5.13% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 4,161K shares representing 2.85% ownership of the company. In its prior filing, the firm reported owning 4,081K shares , representing an increase of 1.92%. The firm increased its portfolio allocation in RMD by 4.40% over the last quarter.
VIMSX - Vanguard Mid-Cap Index Fund Investor Shares holds 3,236K shares representing 2.22% ownership of the company. In its prior filing, the firm reported owning 3,163K shares , representing an increase of 2.27%. The firm increased its portfolio allocation in RMD by 7.62% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
